PCRX
NASDAQ · Pharmaceuticals
Pacira Biosciences Inc
$25.02
-0.56 (-2.19%)
Open$25.67
Previous Close$25.58
Day High$25.68
Day Low$24.94
52W High$27.66
52W Low$18.80
Volume—
Avg Volume793.2K
Market Cap1.01B
P/E Ratio196.83
EPS$0.13
SectorPharmaceuticals
Analyst Ratings
Buy
12 analysts
Price Target
-9.2% upside
Current
$25.02
$25.02
Target
$22.71
$22.71
$15.64
$22.71 avg
$35.67
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 651.86M | 633.49M | 216.59M |
| Net Income | 6.31M | 5.52M | 41.33M |
| Profit Margin | 1.0% | 0.9% | 19.1% |
| EBITDA | 57.88M | 53.43M | 75.27M |
| Free Cash Flow | — | — | 28.35M |
| Rev Growth | +2.9% | +2.9% | +14.7% |
| Debt/Equity | 0.54 | 0.54 | 0.92 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |